Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti–Vascular Endothelial Growth Factor Agents Article Swipe
Rebecca Evans
,
Barnaby C Reeves
,
Maureen G. Maguire
,
Daniel Martín
,
Alyson Muldrew
,
Tünde Pető
,
Chris Rogers
,
Usha Chakravarthy
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1001/jamaophthalmol.2020.3001
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1001/jamaophthalmol.2020.3001
Greater variation in retinal thickness in eyes with nAMD during treatment with anti-VEGF was associated with worse BCVA and development of fibrosis and macular atrophy in these post hoc analyses, despite protocol-directed treatment frequency. Practitioners may want to consider variation in retinal thickness when advising patients about their prognosis.
Related Topics To Compare & Contrast
Vs
Medicine
Vs
Chemotherapy
Concepts
Medicine
Macular degeneration
Ophthalmology
Choroidal neovascularization
Visual acuity
Quartile
Retinal
Ranibizumab
Randomized controlled trial
Bevacizumab
Surgery
Internal medicine
Confidence interval
Chemotherapy
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1001/jamaophthalmol.2020.3001
- https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2769560/jamaophthalmology_evans_2020_oi_200060_1601757551.32075.pdf
- OA Status
- hybrid
- Cited By
- 128
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3072257851
All OpenAlex metadata
Raw OpenAlex JSON
No additional metadata available.